GM-CSF vs placebo
Serious adverse events · newly diagnosed patients with myelodysplastic syndromes
1 finding from 1 review
- Granulocyte and granulocyte‐macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic… 2016 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 149 participantsLow